HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

[Alpha interferon in the therapy of polycythemia vera].

Abstract
In previous researches recombinant interferon alpha (IFN-alpha) has been demonstrated to significantly control red cell mass and thrombocytemia in patients with polycythemia vera (PV). Further evaluation of drug effectiveness and of modalities of maintenance therapy is warranted. We treated four patients with PV according to PVSG criteria with IFN-alpha (3 MU subcutaneously three times a week) for five months. Thereafter the starting dose was reduced to 1.5 MU three times a week. Treatment with IFN-alpha at the higher dosage induced regression in sizes of the spleen and a return to normal levels of peripheral blood platelets and leukocytes. Phlebotomies, previously performed to keep under control hematocrit values, were no more needed. During maintenance treatment with IFN-alpha reduced dose platelet level remained in the normal range, spleen size did not show further variation but hematocrit slowly rose and phlebotomies had to be resumed. These results confirm IFN-alpha effectiveness in PV, but suggest the need of relatively high dosages of the drug and difficulties in switching to a maintenance treatment.
AuthorsG Castello, R Lerza, D Cavallini, P Ballarino, A Cerruti, G Bogliolo, I Pannacciulli
JournalRecenti progressi in medicina (Recenti Prog Med) Vol. 87 Issue 1 Pg. 7-11 (Jan 1996) ISSN: 0034-1193 [Print] Italy
Vernacular TitleL'interferone alfa nella terapia della policitemia vera.
PMID8711255 (Publication Type: English Abstract, Journal Article)
Chemical References
  • Interferon-alpha
Topics
  • Aged
  • Drug Administration Schedule
  • Follow-Up Studies
  • Hematocrit
  • Humans
  • Injections, Subcutaneous
  • Interferon-alpha (administration & dosage, therapeutic use)
  • Male
  • Middle Aged
  • Phlebotomy
  • Polycythemia Vera (drug therapy)
  • Treatment Outcome

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: